EMEA (Europe, Middle East and Africa) 23-Valent Pneumococcal Polysaccharide Vaccine Market Report 2018

March 2018 | 105 pages | ID: ED2358C966BQEN
QYResearch

Abstracts

In this report, the EMEA 23-Valent Pneumococcal Polysaccharide Vaccine market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of 23-Valent Pneumococcal Polysaccharide Vaccine for these regions, from 2013 to 2025 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA 23-Valent Pneumococcal Polysaccharide Vaccine market competition by top manufacturers/players, with 23-Valent Pneumococcal Polysaccharide Vaccine sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• MSD
• Sanofipasteur
• CDIBP

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Single Dose Vial
• Pre-Filled Syringe

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Children (2-10 Age)
• Adult (10-64 Age)
• Geriatric (More Than 65 Age)

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) 23-Valent Pneumococcal Polysaccharide Vaccine Market Report 2018

1 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE OVERVIEW

1.1 Product Overview and Scope of 23-Valent Pneumococcal Polysaccharide Vaccine
1.2 Classification of 23-Valent Pneumococcal Polysaccharide Vaccine
  1.2.1 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Single Dose Vial
  1.2.4 Pre-Filled Syringe
1.3 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Market by Application/End Users
  1.3.1 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.2 Children (2-10 Age)
  1.3.3 Adult (10-64 Age)
  1.3.4 Geriatric (More Than 65 Age)
1.4 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Market by Region
  1.4.1 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 Europe Status and Prospect (2013-2025)
  1.4.3 Middle East Status and Prospect (2013-2025)
  1.4.4 Africa Status and Prospect (2013-2025)
1.5 EMEA Market Size (Value and Volume) of 23-Valent Pneumococcal Polysaccharide Vaccine (2013-2025)
  1.5.1 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2025)
  1.5.2 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2013-2025)

2 EMEA 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Market Competition by Players/Manufacturers
  2.1.1 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Market Share of Major Players (2013-2018)
  2.1.2 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Share by Players (2013-2018)
  2.1.3 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Players (2013-2018)
2.2 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine (Volume and Value) by Type/Product Category
  2.2.1 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Type (2013-2018)
  2.2.2 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Type (2013-2018)
  2.2.3 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Type (2013-2018)
2.3 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine (Volume) by Application
2.4 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine (Volume and Value) by Region
  2.4.1 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Region (2013-2018)
  2.4.2 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Region (2013-2018)
  2.4.3 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales Price by Region (2013-2018)

3 EUROPE 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Value (2013-2018)
  3.1.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Growth Rate (2013-2018)
  3.1.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2013-2018)
3.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Type
3.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Application
3.4 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume by Countries (2013-2018)
  3.4.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Countries (2013-2018)
  3.4.3 Germany 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
  3.4.4 France 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
  3.4.5 UK 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
  3.4.6 Russia 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
  3.4.7 Italy 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
  3.4.8 Benelux 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)

4 MIDDLE EAST 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Value (2013-2018)
  4.1.1 Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Growth Rate (2013-2018)
  4.1.2 Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2013-2018)
4.2 Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Type
4.3 Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Application
4.4 Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume by Countries (2013-2018)
  4.4.2 Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Countries (2013-2018)
  4.4.3 Saudi Arabia 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
  4.4.4 Israel 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
  4.4.5 UAE 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
  4.4.6 Iran 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)

5 AFRICA 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Value (2013-2018)
  5.1.1 Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Growth Rate (2013-2018)
  5.1.2 Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2013-2018)
5.2 Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Type
5.3 Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Application
5.4 Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume by Countries (2013-2018)
  5.4.2 Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Countries (2013-2018)
  5.4.3 South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
  5.4.4 Nigeria 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
  5.4.5 Egypt 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)
  5.4.6 Algeria 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2018)

6 EMEA 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 MSD
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 23-Valent Pneumococcal Polysaccharide Vaccine Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Sanofipasteur
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 23-Valent Pneumococcal Polysaccharide Vaccine Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 CDIBP
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 23-Valent Pneumococcal Polysaccharide Vaccine Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview

7 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE MANUFACTURING COST ANALYSIS

7.1 23-Valent Pneumococcal Polysaccharide Vaccine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 23-Valent Pneumococcal Polysaccharide Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of 23-Valent Pneumococcal Polysaccharide Vaccine Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE MARKET FORECAST (2018-2025)

11.1 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Price Forecast (2018-2025)
  11.1.1 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate Forecast (2018-2025)
  11.1.2 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate Forecast (2018-2025)
  11.1.3 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Price and Trend Forecast (2018-2025)
11.2 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.4 Middle Eastt 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.5 Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.6 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2018-2025)
11.7 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume (K Units) by Type (2013-2025)
Figure EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume Market Share by Type (Product Category) in 2017
Figure Single Dose Vial Product Picture
Figure Pre-Filled Syringe Product Picture
Figure EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume (K Units) by Application (2013-2025)
Figure EMEA Sales Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Application in 2017
Figure Children (2-10 Age) Examples
Table Key Downstream Customer in Children (2-10 Age)
Figure Adult (10-64 Age) Examples
Table Key Downstream Customer in Adult (10-64 Age)
Figure Geriatric (More Than 65 Age) Examples
Table Key Downstream Customer in Geriatric (More Than 65 Age)
Figure EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (Million USD) by Region (2013-2025)
Figure Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Growth Rate (2013-2025)
Figure EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Market Major Players Product Sales Volume (K Units) (2013-2018)
Table EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume (K Units) of Major Players (2013-2018)
Table EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Players (2013-2018)
Figure 2017 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Players
Figure 2017 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Players
Figure EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Market Major Players Product Revenue (Million USD) (2013-2018)
Table EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) by Players (2013-2018)
Table EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Players (2013-2018)
Table 2017 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Players
Table 2017 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Players
Table EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price (USD/Unit) by Players (2013-2018)
Table EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) and Market Share by Type (2013-2018)
Table EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Type (2013-2018)
Figure Sales Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Type (2013-2018)
Figure EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2013-2018)
Table EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) and Market Share by Type (2013-2018)
Table EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Type (2013-2018)
Figure Revenue Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Type in 2017
Table EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price (USD/Unit) by Type (2013-2018)
Table EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) and Market Share by Application (2013-2018)
Table EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Application (2013-2018)
Figure Sales Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Application (2013-2018)
Figure EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2017
Table EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) and Market Share by Region (2013-2018)
Table EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Region (2013-2018)
Figure Sales Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Region (2013-2018)
Figure EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share in 2017
Table EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) and Market Share by Region (2013-2018)
Table EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Region (2013-2018)
Figure Revenue Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Region (2013-2018)
Figure EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Regions in 2017
Table EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales Price (USD/Unit) by Region (2013-2018)
Figure Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2013-2018)
Table Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) by Type (2013-2018)
Table Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Type (2013-2018)
Figure Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Type in 2017
Table Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) by Application (2013-2018)
Table Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Application (2013-2018)
Figure Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Application in 2017
Table Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) by Countries (2013-2018)
Table Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries (2013-2018)
Figure Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries (2013-2018)
Figure Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries in 2017
Table Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) by Countries (2013-2018)
Table Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries (2013-2018)
Figure Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries (2013-2018)
Figure Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries in 2017
Figure Germany 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure France 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure UK 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure Russia 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure Italy 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure Benelux 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) and Growth Rate (2013-2018)
Table Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) by Type (2013-2018)
Table Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Type (2013-2018)
Figure Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Type (2013-2018)
Table Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) by Applications (2013-2018)
Table Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Applications (2013-2018)
Figure Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2017
Table Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume (K Units) by Countries (2013-2018)
Table Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume Market Share by Countries (2013-2018)
Figure Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume Market Share by Countries in 2017
Table Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) by Countries (2013-2018)
Table Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries (2013-2018)
Figure Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries (2013-2018)
Figure Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries in 2017
Figure Saudi Arabia 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure Israel 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure UAE 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure Iran 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) and Growth Rate (2013-2018)
Table Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) by Type (2013-2018)
Table Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2013-2018)
Figure Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2013-2018)
Figure Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2017
Table Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) by Application (2013-2018)
Table Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2013-2018)
Figure Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2013-2018)
Table Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume (K Units) by Countries (2013-2018)
Table Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries (2013-2018)
Figure Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries (2013-2018)
Figure Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries in 2017
Table Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) by Countries (2013-2018)
Table Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries (2013-2018)
Figure Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries (2013-2018)
Figure Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries in 2017
Figure South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure Nigeria 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure Egypt 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure Algeria 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) and Growth Rate (2013-2018)
Table MSD 23-Valent Pneumococcal Polysaccharide Vaccine Basic Information List
Table MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share in EMEA (2013-2018)
Figure MSD 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share in EMEA (2013-2018)
Table Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Basic Information List
Table Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share in EMEA (2013-2018)
Figure Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share in EMEA (2013-2018)
Table CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Basic Information List
Table CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share in EMEA (2013-2018)
Figure CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share in EMEA (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 23-Valent Pneumococcal Polysaccharide Vaccine Industrial Chain Analysis
Table Raw Materials Sources of 23-Valent Pneumococcal Polysaccharide Vaccine Major Manufacturers in 2017
Table Major Buyers of 23-Valent Pneumococcal Polysaccharide Vaccine
Table Distributors/Traders List
Figure EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate Forecast (2018-2025)
Figure EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Price (USD/Unit) and Trend Forecast (2018-2025)
Table EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) Forecast by Region (2018-2025)
Figure EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Region (2018-2025)
Table EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) Forecast by Region (2018-2025)
Figure EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Region (2018-2025)
Table Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) Forecast by Countries (2018-2025)
Figure Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Countries (2018-2025)
Table Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Countries (2018-2025)
Table Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) Forecast by Countries (2018-2025)
Figure Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Countries (2018-2025)
Table Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Countries (2018-2025)
Table Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) Forecast by Countries (2018-2025)
Figure Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Countries (2018-2025)
Table Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Countries (2018-2025)
Table EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) Forecast by Type (2018-2025)
Figure EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Type (2018-2025)
Table EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) Forecast by Application (2018-2025)
Figure EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources